Skip to main content

Total Hip Arthroplasty (THA)

0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
1 program
Mpact 3D Metal MonolithN/A1 trial
Active Trials
NCT06748885Recruiting88Est. Dec 2030
Biocorp
BiocorpFrance - Issoire
1 program
PENG BlockN/A1 trial
Active Trials
NCT07040423Not Yet Recruiting6Est. Oct 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
BiocorpPENG Block
MedactaMpact 3D Metal Monolith

Clinical Trials (2)

Total enrollment: 94 patients across 2 trials

MRI-Based Assessment of Local Anesthetic Spread in the PENG Block Compartment

Start: Jun 2025Est. completion: Oct 20266 patients
N/ANot Yet Recruiting
NCT06748885MedactaMpact 3D Metal Monolith

Mpact 3D Metal Monolit Study

Start: Feb 2024Est. completion: Dec 203088 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 94 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.